Influenza virus causes a serious respiratory illness affecting nearly 1 out of 5 Americans annually, resulting in 226,000 hospitalizations and up to 49,000 deaths. Apart from yearly seasonal outbreaks, influenza virus can cause frequent epidemics and occasional pandemics in humans. Influenza A virus can also infect a variety of other species including poultry, aquatic birds, horses, pigs and seals. Hence, influenza viruses are a threat not only humans but also to domestic poultry and wildlife, and viral outbreaks can have a major socio-economic impact worldwide. Accumulating evidence indicates that early innate immune responses to influenza infection largely determine the outcome of the infection and survival of the host. This early response to influenza virus infection is initiated by the activation of innate immune sensors called the """"""""pattern-recognition receptors (PRRs)"""""""" present in the host cell. They detect the viral components and trigger the production of type I interferon (IFN-a/?) and other cytokines. This first response is critical for effectively mounting antiviral responses against the virus and development of proper adaptive immune response. Not surprisingly, influenza virus blocks the production of type I IFN at several cellular steps via its multifunctional protein NS1 and thereby dampens the host immune response. However, little is known about the early innate immune responses activated by PRRs, how their activation controls viral replication, the respiratory cell types involved in protection and contribution of NS1 in influenza virus virulence. These studies are challenging to investigate in vivo, partly because there is no efficient replication-competent virus expressing an easily traceable reporter gene. So, the current proposal is aimed to gain a stronger fundamental understanding of (Aim1) the detailed dynamics of interplay between PRRs and influenza virus, and (Aim2) the importance of viral-host antagonist NS1 in limiting host immune response and viral pathogenesis, using the recently generated influenza GFP/RFP reporter viruses. The information gained from this study can be exploited in developing new therapeutic strategies to prevent influenza virus spreading and reducing disease. Early innate immune response against the influenza virus infection plays a critical role in the timely control of infection, and the quality of the early host response determines the fate of the host. This proposal, using the newly generated influenza virus carrying fluorescent reporters, aims to understand how the host innate immune sensors help control virus infection and how the viral factor(s) limit host immune response. This knowledge can be useful in devising novel therapeutics against influenza viruses.

Public Health Relevance

Early innate immune response against the influenza virus infection plays a critical role in the timely control of infection, and the quality of the early host response determines the fate of the host. This proposal, using the newly generated influenza virus carrying fluorescent reporters, aims to understand how the host innate immune sensors help control virus infection and how the viral factor(s) limit host immune response. This knowledge can be useful in devising novel therapeutics against influenza viruses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Career Transition Award (K99)
Project #
1K99AI095320-01
Application #
8164891
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Hauguel, Teresa M
Project Start
2011-05-01
Project End
2013-01-31
Budget Start
2011-05-01
Budget End
2013-01-31
Support Year
1
Fiscal Year
2011
Total Cost
$113,071
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Danzy, Shamika; Studdard, Lydia R; Manicassamy, Balaji et al. (2014) Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells. J Virol 88:13436-46
Schmolke, Mirco; Patel, Jenish R; de Castro, Elisa et al. (2014) RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection. MBio 5:e01006-14
White, Steven R; Loisel, Dagan A; Stern, Randi et al. (2013) Human leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines. Respir Res 14:4
Perez, Jasmine T; GarcĂ­a-Sastre, Adolfo; Manicassamy, Balaji (2013) Insertion of a GFP reporter gene in influenza virus. Curr Protoc Microbiol Chapter 15:Unit 15G.4
Nicodemus-Johnson, Jessie; Laxman, Bharathi; Stern, Randi K et al. (2013) Maternal asthma and microRNA regulation of soluble HLA-G in the airway. J Allergy Clin Immunol 131:1496-503
Medina, Rafael A; Stertz, Silke; Manicassamy, Balaji et al. (2013) Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Sci Transl Med 5:187ra70
Varga, Zsuzsanna T; Grant, Alesha; Manicassamy, Balaji et al. (2012) Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol 86:8359-66
Marazzi, Ivan; Ho, Jessica S Y; Kim, Jaehoon et al. (2012) Suppression of the antiviral response by an influenza histone mimic. Nature 483:428-33
Hufford, Matthew M; Richardson, Graham; Zhou, Haixia et al. (2012) Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One 7:e46581
Ward, Samuel E; Kim, Hyun Seok; Komurov, Kakajan et al. (2012) Host modulators of H1N1 cytopathogenicity. PLoS One 7:e39284